TADALAFIL (TADALAFIL) — FDA Approval ANDA210716 (CHARTWELL RX)
TADALAFIL (TADALAFIL) — FDA Approval ANDA210716 (CHARTWELL RX) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: TADALAFIL; Active ingredients: TADALAFIL; Application number: ANDA210716.
| Brand name | TADALAFIL |
|---|---|
| Active ingredients | TADALAFIL |
| Application number | ANDA210716 |
| Sponsor | CHARTWELL RX |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 4 |
| First approval date | 20201229 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →